Halozyme Therapeutics Inc (HALO)

[maumar]

On its own, the stock buyback program is not a disaster but it shows a lack of confidence in their ability to use cash to grow their business. And I think to expect that it will make a big difference is wishful thinking. I guess it shows they think the stock is undervalued. Maybe. I would much rather see Helen or other insiders buy in the open market, which I believe they haven't done since the stock was at $14.

The stock has huge resistance starting at $35 and all the way to $55 and if they buy, say, 7 million shares in the next 12 months, isn't that only 5% of all outstanding shares? That can hopefully keep the stock from cratering but we'll need some significant and unexpected good news to even go back to $45. The problem I see is that we don't have major catalysts in the next 24 months. New deals will help but we are going to need one huge transformative deal or several small ones.